The overall objective of Cancer Center Planning and Evaluation is to provide effective and integrated processes to ensure that the Cancer Center fulfills its mission set by the NCI and the University of Alabama at Birmingham. These planning activities involve all of our Senior Leaders, Program Leaders, and on occasion, members of the Cancer Center. Major planning occurs in the Director's Council, made up of Senior Leadership, with significant advice in planning and evaluation from the External and Internal Advisory Committees. Evaluation consists of both external review by the External Advisory Committee, and two avenues of critical internal review. Internal review comes both from review of the entire CCC by an Internal Advisory Committee made up of leaders across the UAB campus, and evaluation of the shared facilities by an internal committee. Additional planning occurs in the bi-monthly Program Leaders meeting, the annual Program and Senior Leadership Retreat, and the biennial Cancer Center Strategic Planning Retreat. Some ofthe specific planning processes include the following. ? Our External Advisory Committee (EAC) consists of ten members with extensive Cancer Center leadership and nationally recognized expertise required to critically evaluate and advise regarding the Cancer Center's programmatic and organizational development. The EAC meets annually. ? The Center holds an annual center-wide research retreat in order to stimulate transdisciplinary research collaboration and program development as well as an annual priority and strategic planning retreat for identification of Cancer Center scientific priorities, recruitment needs, and for major program evaluation and development. This retreat includes leadership on an annual basis and the entire Cancer Center membership on a biennial basis. ? The Cancer Center also sponsors community-based conferences to facilitate interactions with the community and providers who can be extremely important to our clinical and prevention trials. ? The major planning and evaluation activity occurs in the monthly Director's Council composed of all Senior Leaders in the Cancer Center.
A Comprehensive Cancer Center represents a major investment by the NCI, and, by extension, the taxpayers of the United States. Effective planning and evaluation are critical to assure that the goals of the NCI and ofthe Public Health Service are being met. Our Planning and Evaluation processes are designed to meet that need.
|Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27|
|Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:|
|Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14|
|Garner, Evan F; Williams, Adele P; Stafman, Laura L et al. (2018) FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Sci Rep 8:6913|
|Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210|
|Fancy, Romone M; Kim, Harrison; Napier, Tiara et al. (2018) Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells. J Cell Biochem 119:6216-6230|
|Barrington, David A; Champion, Macie L; Boitano, Teresa K L et al. (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337-340|
|Banerjee, N Sanjib; Wang, Hsu-Kun; Beadle, James R et al. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Res 150:164-173|
|Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34|
|Kleinpeter, Alex B; Jureka, Alexander S; Falahat, Sally M et al. (2018) Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds. J Biol Chem 293:14659-14668|
Showing the most recent 10 out of 747 publications